COVID-19 Biological Samples Collection

N/ATerminatedNCT04332016

University Hospital, Bordeaux615 enrolled

Overview

The coronavirus disease 2019 (COVID-19) outbreak is now considered as a public health emergency of international concern by the World Health Organization. In the context of the health emergency, research on the pathogen (the SARS-CoV-2 coronavirus), the disease and the therapeutic care is being organized. Research projects require the use of biological samples. This study aims at setting up a collection of biological samples intended for application projects in any discipline. The main objective of the study is to collect, process and store biological samples from patients and caregivers infected with SARS-CoV-2 (COVID-19) at the biological ressources center of the Bordeaux University Hospital.

Study Type

OBSERVATIONAL

Enrollment

615

Conditions

Infection Viral

Interventions

biological samples collectionOTHER

collection of whole blood samples, urine and stool samples, upper respiratory samples, post-mortem biopsies

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Patients / caregivers treated at Bordeaux University Hospital for asymptomatic or symptomatic infection by SARS -CoV-2 * men and women, adults and minors as well as pregnant or breastfeeding women * patients who died following infection with SARS-CoV-2 (specific criterion for post-mortem biopsies) * Be affiliated with or beneficiary of a social security scheme * Free and informed consent obtained and signed by the patient Exclusion Criteria: * Under guardianship or curatorship

Outcomes

Primary Outcomes

COVID-19 desease description

From blood samples: protein levels, whole genome sequence, transcriptomic analysis data. From upper respiratory samples: protein levels, virus transcriptomic analysis data. From stool: microbiota analysis data. From urine: protein level.

Time frame: Inclusion visit (Day 1)